IASLC 2021 World Conference on Lung Cancer *

September 8-14, 2021; Virtual Meeting
Review Capsule summaries and expert analysis of key studies presented at the IASLC 2021 World Conference on Lung Cancer virtual meeting.

Share

Program Content

12 Capsule Summary Slidesets

Activities

IMpower010 Subgroup Analysis
IMpower010 Subgroup Analysis: Outcomes by Therapy Prior to Adjuvant Atezolizumab in Patients With Resected Stage IB-IIIA NSCLC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 15, 2021

Expires: September 14, 2022

Larotrectinib for TRK Fusion+ Lung Cancer
Larotrectinib in Patients With TRK Fusion–Positive Lung Cancer
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 15, 2021

Expires: September 14, 2022

TROPION-PanTumor01 Update
Phase I TROPION-PanTumor01: Updated Analysis of Datopotamab Deruxtecan, a TROP2-Directed ADC, in Pretreated Advanced NSCLC Cohort
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 16, 2021

Expires: September 15, 2022

EMPOWER-Lung 1: LA NSCLC
Phase III EMPOWER-Lung 1 Subgroup Analysis: First-line Cemiplimab vs Chemotherapy in Patients With Locally Advanced NSCLC With PD-L1 ≥50%
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 16, 2021

Expires: September 15, 2022

CheckMate 9LA Brain Mets
CheckMate 9LA Post Hoc Analysis: First-line Nivolumab + Ipilimumab + CT in Patients With Advanced NSCLC and Brain Metastases
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 17, 2021

Expires: September 16, 2022

ATLANTIS
Phase III ATLANTIS: Lurbinectedin + Doxorubicin vs CAV or Topotecan in Relapsed SCLC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 17, 2021

Expires: September 16, 2022

DZD9008 in <i>EGFR</i> ex20ins+ Adv NSCLC
Phase I Studies of Selective EGFR/HER2 Inhibitor DZD9008 in Patients With Advanced NSCLC and EGFR Exon 20 Insertion Mutations
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 20, 2021

Expires: September 19, 2022

ATEZO-BRAIN
ATEZO-BRAIN: Atezolizumab + Carboplatin/Pemetrexed in Advanced Nonsquamous NSCLC With Untreated Brain Metastases
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 20, 2021

Expires: September 19, 2022

CHRYSALIS METex14 Cohort
Phase I CHRYSALIS: Amivantamab, an EGFR-MET Bispecific Antibody, in Advanced NSCLC with MET Exon 14 Skipping Mutations
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 23, 2021

Expires: September 22, 2022

Mobocertinib After EGFR TKI
Phase I/II Trial of Mobocertinib in EGFR ex20ins+ Advanced NSCLC: Analysis of Patient Cohort With Disease Control on Prior EGFR TKI Therapy
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 23, 2021

Expires: September 22, 2022

POSEIDON: Durvalumab ± Tremelimumab + CT
Phase III POSEIDON: First-line Durvalumab ± Tremelimumab + Chemotherapy in Metastatic NSCLC
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022
CAR T ± Pembro in MPM
Phase I Results of Ongoing Trial Assessing Mesothelin-Targeted CAR T-Cell Therapy ± Pembrolizumab in Malignant Pleural Cancers
Conference Coverage
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Activities

Key Studies at WCLC 2021
An Expert’s Guide to WCLC 2021: A Preview of the Top Abstracts
Clinical Thought
Conference Coverage
Congratulations: You achieved a completion on 04/09/2022

Released: September 07, 2021

Expires: September 06, 2022

2021 WCLC Highlights
Independent Conference Coverage of the IASLC 2021 World Conference on Lung Cancer
Conference Coverage
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: November 18, 2021

Expires: November 17, 2022

Faculty

cover img faculity

Anne Chiang, MD, PhD

Associate Professor
Yale University School of Medicine
Deputy Chief Medical Officer
Chief Network Officer
Smilow Cancer Hopsital
New Haven, Connecticut

cover img faculity

Thomas Stinchcombe, MD

Medical Oncologist
Thoracic Oncology Program
Duke University Medical Center
Durham, North Carolina

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Bayer Healthcare Pharma

Daiichi Sankyo, Inc.

Janssen administered by Scientific Affairs

Janssen Pharmaceutica NV

Millennium Pharmaceuticals Inc Subsidary of Takeda

Regeneron Pharmaceuticals, Inc. and Sanofi Genzyme

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.